Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go?

@article{White2010MeningococcalSC,
  title={Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go?},
  author={C. White and Jeff Scott},
  journal={Canadian journal of public health = Revue canadienne de sante publique},
  year={2010},
  volume={101 1},
  pages={
          12-4
        }
}
  • C. White, Jeff Scott
  • Published 2010
  • Medicine
  • Canadian journal of public health = Revue canadienne de sante publique
Since routine meningococcal C conjugate vaccination was introduced into Canada in 2002, there have been a large regional variation in the routine programs, changes to the timing of the infant series in some provinces, and wide differences in catch-up programs. As immunization is viewed as a provincial responsibility, less attention has been paid to determining national coverage rates and the direct and indirect effects of the widely varying provincial/territorial vaccination programs on the… Expand
Meningococcal conjugate vaccines: optimizing global impact
Epidemiology of meningococcal disease in the Panamanian pediatric population, 1998-2008.
Design and evaluate a model (prototype) for immunization record system in distributed healthcare
...
1
2
...

References

SHOWING 1-10 OF 19 REFERENCES
Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.
Conquering the meningococcus.
  • D. Stephens
  • Biology, Medicine
  • FEMS microbiology reviews
  • 2007
...
1
2
...